Biotechnology News

April 3, 2014

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it will conduct an intercontinental...

April 3, 2014

ST. LOUIS--(BUSINESS WIRE)--Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, today released the latest commercial version of the Broad Institute’s Genome Analysis Toolkit (GATK...

April 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Impact 2020 is an in-depth analysis and prediction of trends, opportunities and threats to life sciences in Massachusetts. This strategic report by MassBio is a call to action for stakeholders.

April 3, 2014

RAMSEY, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious...

April 3, 2014

MENLO PARK, Calif.--(BUSINESS WIRE)--Auxogyn, Inc., a company dedicated to advancing women’s reproductive health, today announced an exclusive license agreement with Merck Serono, the biopharmaceutical division of Merck KGaA, Darmstadt.

April 3, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that positive preclinical results from an in vivo study of aldoxorubicin in an animal...

April 3, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ: KMDA)(TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today a U.S.-based proof-of-concept (POC) study with Glassia® to treat graft-...

April 3, 2014

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--Bioprinting Investment Puts RBCC at Forefront of 3-D Revolution

April 3, 2014

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today financial results for its third quarter ended February 28, 2014. Third Quarter Financial Results Consolidated net sales increased 6.6% (7.5% constant currency) worldwide to approximately...

April 2, 2014

WASHINGTON--(BUSINESS WIRE)--BIO and the Wireless-Life Sciences Alliance (WLSA) today announced the inaugural Digital Health Zone & Forum at the 2014 BIO International Convention, taking place June 23-26 in San Diego, CA

April 2, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced topline results from a Phase 3 clinical trial (Study GS-US-334-0118) in Japan evaluating the once-daily nucleotide analog polymerase inhibitor sofosbuvir in...

April 2, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced the appointment of Pankaj Bhargava, M.D., as Chief Medical Officer. Dr. Bhargava brings to...

April 2, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori announces that CEO Chris Calhoun will retire from the role of CEO effective immediately.

April 2, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS) today announced that it is offering $125 million of shares of its common stock in a proposed underwritten public offering. The offering is subject to market conditions and there...

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 13th Annual Needham Healthcare Conference on Wednesday,...

April 2, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the 13th Annual Needham Healthcare Conference being held April 8-9, 2014 at the Westin Grand Central Hotel in New York...

April 2, 2014

BROOMFIELD, Colo.--(BUSINESS WIRE)--Affygility Solutions announces the immediate availability of its occupational exposure limit (OEL) monograph for delta 9-tetrahydrocannabinol (THC), the active ingredient in marijuana.

April 2, 2014

PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--VGTI Florida scientists awarded U.S. Patent No. 8,647,822 titled DETERMINING WHETHER A TEST COMPOUND MODULATES PD-1 ACTIVITY IN ACTIVATED IMMUNE CELLS USING GENE EXPRESSION PROFILES.

April 2, 2014

ACTON, Mass.--(BUSINESS WIRE)--Cognoptix President and CEO Paul Hartung told a group of analysts yesterday: “Our vision is to change the course of Alzheimer’s disease by enabling early diagnosis at the point of care.” (CLICK HERE FOR VIDEO) Mr....

April 2, 2014

LONDON--(BUSINESS WIRE)--Process Systems Enterprise has acquired a significant equity stake in BlueWatt Engineering Sàrl, a company with unique technology for wastewater systems optimisation.

April 2, 2014

NEW YORK--(BUSINESS WIRE)--The staggering rise of Autism and the troubling lack of urgency by the medical establishment to address this crisis has led the founders of The Thinking Moms’ Revolution (authors of the book, The Thinking Moms’...

April 2, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Fresenius Kabi announced today that Dana-Farber Cancer Institute has received the company’s first Fresenius Kabi Scientific Investigator Award. The winning submission, “Extracorporeal Photopheresis Combined with...

April 2, 2014

HOUSTON--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced that Pernix CEO Doug Drysdale is scheduled to present at the 13th Annual Needham...

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea will present at the Needham & Company 13th Annual Healthcare Conference on April 9, 2014.

April 2, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--23andMe Builds Out Leadership Team

April 2, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that it will have two poster presentations...

April 2, 2014

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to...

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pr-Clinical Research Shows ACC Inhibitors Dramatically Impact Tumor Growth in Small Cell Lung Cancer and Liver Cancer

April 2, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track designations for both the intravenous (IV) and oral formulations of the...

April 2, 2014

WOBURN, Mass.--(BUSINESS WIRE)--ArQule is scheduled to present at the Needham Healthcare Conference on April 9, 2014.

April 2, 2014

CHICAGO--(BUSINESS WIRE)--Navigant (NYSE: NCI) announced today that it has acquired substantially all of the Life Sciences practice of Leerink Swann Consulting, LLC, the consulting arm of Leerink Holdings, LLC, a leading investment bank...

April 2, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Richard A. Young, Syros Pharmaceuticals Scientific Founder, to Open AACR Annual Meeting 2014 with Address Highlighting His Pioneering Gene Control Research.

April 2, 2014

EAST PROVIDENCE, R.I.--(BUSINESS WIRE)--IlluminOss announces it has received a Notice of Allowance from the U.S. Patent and Trademark Office for instruments used in the company’s proprietary Photodynamic Bone Stabilization System (PBSS).

April 2, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--The Tech Council of Maryland announced today the finalists for its 26th Annual Industry Awards celebration.

April 2, 2014

PALO ALTO, Calif. & LEXINGTON, Mass.--(BUSINESS WIRE)--Syapse and N-of-One announced a partnership to make N-of-One’s clinical interpretation available to hospitals and laboratories through interfaces in the Syapse platform.

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mersana has received a patent with broad coverage over its Fleximer Antibody Drug Conjugate technology. Mersana's conjugation technology offers several improvements over existing ADC platforms.

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has adopted a positive...

April 2, 2014

MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics announced the AEGIS-2 clinical trial has met its primary endpoint. Its BronchoGen genomic test improves the accuracy of lung cancer diagnosis in combination with bronchoscopy.

April 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the appointment of Hugh M. Cole to the position of senior vice president and chief business officer. Mr. Cole will be responsible for global business...

April 2, 2014

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that they have submitted the final study report for the Phase 1 study comparing the...

April 2, 2014

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Newborn Screening Solution from AB SCIEX Provides Early Detection Indicators of Metabolic Disorders to Help Doctors in Europe Make Babies’ Health More Predictable

April 2, 2014

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (OMX Nordic Exchange: AERO)(STO:AERO-B) today announced that NICE (National Institute for Health and Care Excellence) has published guidelines (...

April 2, 2014

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, an innovative molecular information company, announces a new comprehensive epilepsy sequencing test designed to sequence 489 genes known to be involved in epilepsy, antiepileptic drug...

April 2, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. The new name better reflects the company’s strong position as a late-stage, purpose-built...

April 2, 2014

ORLANDO, Fla.--(BUSINESS WIRE)--On April 7, 2014, Mazor Robotics (TASE:MZOR; NASDAQ GM:MZOR) will debut and officially launch the new Renaissance Guidance System brain module at the American Association of Neurological Surgeons (AANS) annual...

April 2, 2014

LEE’S SUMMIT, Mo.--(BUSINESS WIRE)--Acceleration earns four out of five 2014 CRO Leadership Awards from Life Science Leader in the categories of Regulatory, Innovation, Productivity and Reliability.

April 2, 2014

LUXEMBOURG--(BUSINESS WIRE)--Advanced Biological Laboratories S.A. enters into exclusive licensing agreement with CRP-Santé for “COMET” software a tool designed for high performance DNA sequencing analysis and classification.